Leader of homeless shelter has job flipped upside down
The pandemic changed just about every aspect of Lori Casson’s job as executive director of Dayspring Center.
Health Care & Life Sciences
Articles
Medical team learned about coronavirus on the fly
Nothing in Indiana University Health pulmonologist Dr. Caitriona Buckley’s 18 years of practicing medicine has even come close to the stress of this past year.
Restaurant focuses on keeping connections and staying in business
Restaurateur Ed Battista says Bluebeard and Amelia’s have gone through radical changes to keep the businesses afloat and maintain the human relationships at their core.
State seeks to regulate pharmacy benefit managers
Three bills advancing through the Indiana General Assembly would provide tighter regulation of pharmacy benefits managers (PBMs).
Real estate firm’s bet on senior health care takes painful turn
The past year has been awful for Carmel-based Invesque, as COVID-19 hurt the full gamut of its health care real estate portfolio, from nursing homes and office buildings to memory-care and assisted-living centers.
Small labs try to nab testing work at big sports events
A huge event that kicks off next month is hanging like a plum: the NCAA men’s basketball tournament.
Lilly’s flush pipeline makes it Wall Street darling
If you follow the daily drumbeat of news emanating out of Lilly Corporate Center, you might not grasp how phenomenally well the company is poised to perform in the coming years.
Apria’s long, bumpy road leads to Indianapolis
Indianapolis’ newest publicly traded company, home-health care provider Apria Inc., is slowly moving its headquarters here, to its regional distribution center on the city’s southeast side.
Hope at Lilly after years of Alzheimer’s failures
Lilly has spent three decades and more than $3 billion trying to find a way to treat Alzheimer’s disease. Its latest drug, donanemab, finally shows real promise.
Anthem paying $594M to settle antitrust litigation, but deal terms might fuel growth
Paying a half-billion-dollar settlement might seem painful, but health care observers say resulting changes to Blue Cross Blue Shield rules are so favorable to Anthem’s growth prospects that the deal is a huge win.
Local senior-living complex more than doubles assisted-living units in $5M expansion
The expansion will consist of 32 new one-bedroom apartments and five two-bedroom residences, bringing to 67 the number of assisted-living apartments at the complex.
Startup quietly building bone marrow bank in Indianapolis
Ossium Health wants to build a huge bank of bone marrow and stem cells from deceased organ donors to treat patient with blood cancers and to improve organ transplantations.
Lilly to help Dutch biotech develop cancer therapies in deal worth up to $1.6B
Merus N.V. specializes is so-called CD3 engaging T-cell therapies, a growing area of cancer research, based on immunotherapy, or using the immune system’s T cells to find and shrink tumors
Bill would require nursing homes to allow ‘compassionate care’ visits during pandemic
The legislation, Senate Bill 202, would allow designated family members to visit residents under end-of-life and other serious circumstances.
Indiana scrambles to get COVID vaccines into arms
As hospitals and health departments scramble to erect temporary clinics, the big questions are how fast states can roll out the vaccines and how long it will take for people to get protected.
Lilly suspends contributions to 4 Indiana Congress members over certification votes
Several other Indiana companies also say they are suspending contributions to all candidates or are taking a close look at the matter.
In midst of pandemic, drugmakers raise prices on hundreds of prescription drugs
So far this month, drugmakers have hiked prices on 636 drugs, according to research by GoodRx, which tracks prescription drug prices and offer a mobile app to help consumers find the lowest prices on hundreds of drugs.
WTHR reporter, anchor McCutcheon leaves for life sciences job
Matt McCutcheon, a reporter and anchor for WTHR-TV Channel 13 since 2013, says he has “retired” from the news industry and is taking a corporate communications gig.
Lilly’s COVID treatment sparks little demand
For a highly touted drug meant to keep throngs of people out of hospitals during a pandemic, Eli Lilly and Co.’s wonder treatment bamlanivimab sure has been slow to catch on.
How you can keep a close eye on vaccinations in Indiana
The state’s new dashboard on COVID-19 vaccines provides interesting breakdowns on who is getting vaccinated, by county, by gender, by race, by age and a host of other statistics sure to please any proud data geek.